2nd Annual Gabelli Funds – Columbia Business School Healthcare Symposium (Virtual) – Friday, November 13, 2020
03 November 2020 - 2:00AM
Business Wire
Join us as we discuss today’s pressing
healthcare issues.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20201102005244/en/
Bunny Ellerin, Director, HPM, Columbia
Business School, MBA, Harvard Business School, BA, Columbia
University (Photo: Business Wire)
CO-HOSTS:
Bunny Ellerin
Director, HPM, Columbia Business
School
Jing He
Biotech Analyst, Gabelli Funds
- MBA, Harvard Business School
- BA, Columbia University
- MBA, Columbia Business School
- MA, Washington University in St. Louis
- BS, Peking University
Time
Agenda
9:00 – 9:10 AM
Welcome
- Bunny Ellerin, Director, Healthcare and Pharmaceutical
Management Program
9:10 – 10:00 AM
Vaccines & Therapeutics to Treat
COVID-19
- David Hering, Regional President, North America, Pfizer
Vaccines
- Dr. Robert Paris, Vice President, Infectious Diseases,
Moderna
- Dr. David Weinreich, Senior Vice President, Global Clinical
Development, Regeneron
- (Moderator) Jing He ‘15, Biotech Analyst, Gabelli Funds
10:10 – 11:00 AM
Health Policy & Reimbursement
Trends
- Dr. Deepa Kumaraiah, Senior Vice President, Service Lines and
Chief Physician, NYP Medical Groups, NewYork-Presbyterian
- Melissa Schulman, Senior Vice President of Government Affairs,
CVS Health
- Professor Michael Sparer, Chair, Health Policy and Management,
Columbia University Mailman School of Public Health
- (Moderator) Jeff Jonas, Portfolio Manager, Gabelli Funds
11:10 – Noon
Healthcare Delivery in a Virtual
World
- Dr. Amy Fahrenkopf, President, HSS Health and Senior Vice
President, Hospital for Special Surgery
- Jason Gorevic, CEO, Teladoc Health
- Dr. Julie Silverstein, Divisional President, Oak Street
Health
- (Moderator) Kevin Kedra, Healthcare Analyst, G.research
Click Here to Register
Gabelli Funds, LLC is a
registered investment adviser with the Securities and Exchange
Commission and is a wholly owned subsidiary of GAMCO Investors,
Inc. (NYSE: GBL).
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201102005244/en/
Douglas R. Jamieson 914-921-5020 djamieson@gabelli.com
Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart
From Jul 2023 to Jul 2024